<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01089218</url>
  </required_header>
  <id_info>
    <org_study_id>postFB fever</org_study_id>
    <nct_id>NCT01089218</nct_id>
  </id_info>
  <brief_title>The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines</brief_title>
  <official_title>The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fever can develop after fiberoptic bronchoscopy (FB) in about 2.5 - 16 % of adult patients.
      We evaluated the impact of oral amoxicillin/clavulanate (AC) on incidence of
      postbronchoscopic fever and pneumonia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For the population being undergone with bronchoscopy, the clinical signs and procedural
      measures for complication of bronchoscopy and cytokines will be checked.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of fever</measure>
    <time_frame>24 hr after bronchoscopy</time_frame>
    <description>time frame for body temperature 24hr before and after bronchoscopy every 4hrs</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of serum cytokines level</measure>
    <time_frame>before bronchoscopy and 24hr after bronchoscopy</time_frame>
    <description>Time frame for cytokine measurement 24hr before brochoscopy - 1hr after bronchosocpy - 24hr after brochoscopy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">241</enrollment>
  <condition>Fever</condition>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control without intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amoxicillin/clavulanate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral amoxicillin/clavulanate 1g (875/125mg)</intervention_name>
    <description>oral amoxicillin/clavulanate 1g (875/125mg) on the day of the procedure 30 minutes prior to the FB</description>
    <arm_group_label>Amoxicillin/clavulanate</arm_group_label>
    <other_name>prophylaxis group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>control</intervention_name>
    <description>no intervention with the same procedure of FB</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients (aged 18 years or older) who underwent FB

        Exclusion Criteria:

          -  concurrent treatment with antibiotics or systemic corticosteroid
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deog Kyeom Kim, MD.</last_name>
    <role>Study Director</role>
    <affiliation>Seoul Metropolitan Government, Seoul National University Boramae Medical Center, 39 Boramae-Gil, Dongjak-Gu, Seoul, Republic of Korea 156-707.</affiliation>
  </overall_official>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2010</study_first_submitted>
  <study_first_submitted_qc>March 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2010</study_first_posted>
  <last_update_submitted>July 19, 2011</last_update_submitted>
  <last_update_submitted_qc>July 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2011</last_update_posted>
  <responsible_party>
    <name_title>Deog Kyeom Kim, MD</name_title>
    <organization>Seoul Metropolitan Government, Seoul National University Boramae Medical Center</organization>
  </responsible_party>
  <keyword>bronchoscopy</keyword>
  <keyword>post-bronchoscopy fever</keyword>
  <keyword>pneumonia</keyword>
  <keyword>cytokines</keyword>
  <keyword>amoxicillin/clavulanate</keyword>
  <keyword>prophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

